Dr. Armand B. Cognetta Jr., MD

Dr. Cognetta practices at Dermatology Associates of Tallahassee PA in Tallahassee, Florida.

Dr. Cognetta's NPI, 1003922592, was assigned on August 21, 2006. Dr. Cognetta graduated from Uconn School Of Medicine in 1979. Dr. Cognetta holds Florida license ME0036591.

Dr. Cognetta's primary practice is Dermatology Associates of Tallahassee PA, at 1707 Riggins Rd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 877-4134.

Dr. Cognetta's primary practice is Dermatology Associates of Tallahassee PA in Tallahassee, Florida. The medical group on file is Dermatology Associates of Tallahassee. Dmand AI also links Dr. Cognetta to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cognetta practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Cognetta's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Cognetta is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cognetta's licenses on file in 5 states: Florida, Alabama, Georgia, North Carolina and South Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Cognetta treats.

CMS data shows 8,056 Medicare services from Dr. Cognetta across 52 procedure codes in 2024, for 985 Medicare patients. Medicare paid $791,778 for them. Every service was in an office.

CMS counts 985 Medicare patients who saw Dr. Cognetta in 2024. The largest group is 75 to 84, with 445 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cognetta's median patient age at 76, with 42% women.

In 2024, Dr. Cognetta wrote 738 Medicare Part D claims for 418 patients. 92% of them were for generic drugs. CMS names the drug for 598 of them, across 10 drugs with 11 or more claims each, at $33,480 in total drug cost. In 2023, CMS named 612 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Cognetta for performance year 2024, reported as part of a group. Dr. Cognetta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 242 procedures of melanoma (skin cancer) excision by Dr. Cognetta, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 72 papers to Dr. Cognetta, published from 2008 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Carcinoma, Squamous Cell and Carcinoma, Basal Cell. Dr. Cognetta has published most often in J Am Acad Dermatol. Dr. Cognetta's most frequent co-authors are Christopher Michael Wolfe, DO, Victor G. Prieto, MD, PhD and William Harris Green.

Dmand AI links Dr. Cognetta to 2 clinical trials. Conditions studied include Melanoma and Nevi and Melanomas. MELA Sciences, Inc. sponsors the most, 2.

CMS Open Payments shows 92 general payments to Dr. Cognetta from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $105,335.

Dmand AI lists 6 awards for Dr. Cognetta, most recently CMS Stage 1 EHR in 2013.

Dr. Cognetta graduated from Uconn School Of Medicine in 1979. Dr. Cognetta is a member of ASDS.

Dr. Cognetta is in network with 16 carriers, including Elevance, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.